LFST LifeStance Health Group Earnings and EPS analysis

  1. Stocks
  2. Healthcare
  3. NASDAQ: LFST
  4. Earnings
?
Relative Growth: Rel. Growth: 63
Relative Strength: Rel. Strength: 68
Relative Valuation: Rel. Valuation: 49
Relative Profitability: Rel. Profitability: 53

EPS in 2026 (TTM): $0.07

Last Report Period Date: Mar 31, 2026

According to the most recent financial data from March 2026, the EPS for the trailing twelve months is $0.07. LifeStance Health Group's EPS for 2025 amounted to $0.03, marking an increase from -$0.15 in 2024. During the quarterly period ending on Mar 31, 2026, LFST's EPS stood at $0.04.

LFST earnings history

Historical annual and quarterly earnings per share (EPS) data for LifeStance Health Group
EPS (TTM)
$0.07
EPS Growth YoY (Quarterly)
N/A
EPS (Quarterly)
$0.04
EPS Growth (Quarterly)
0%

LifeStance Health Group had an annual EPS of $0.03, indicating an increase of 120% from -$0.15 in 2024. LFST's 12-month EPS stands at $0.07 as of March 2026. LifeStance Health Group's annual EPS in 2024 stood at -$0.15, a 70.6% increase year-over-year.

LFST earnings chart

LFST EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
N/A
EPS growth YoY
120%
EPS growth 3Y avg
N/A
EPS growth 5Y avg
N/A

LFST Earnings Waterfall

Breakdown of revenue, profit and net income for LifeStance Health Group

All data is based on quarterly TTM periods, unless otherwise specified.